News GSK licenses Aurobindo, Cipla and Viatris to make generic versions of injectable cabotegravir Pb Staff writerMar 30, 2023
News Operating profit set to grow as Novartis prepares to spin off its Sandoz generics business Pb Staff writer01 February 2023